Teyi Pharmaceutical GroupLtd Balance Sheet Health
Financial Health criteria checks 5/6
Teyi Pharmaceutical GroupLtd has a total shareholder equity of CN¥1.7B and total debt of CN¥640.0M, which brings its debt-to-equity ratio to 36.7%. Its total assets and total liabilities are CN¥2.5B and CN¥749.7M respectively. Teyi Pharmaceutical GroupLtd's EBIT is CN¥80.6M making its interest coverage ratio -17.2. It has cash and short-term investments of CN¥599.9M.
Key information
36.7%
Debt to equity ratio
CN¥640.00m
Debt
| Interest coverage ratio | -17.2x |
| Cash | CN¥599.88m |
| Equity | CN¥1.74b |
| Total liabilities | CN¥749.68m |
| Total assets | CN¥2.49b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 002728's short term assets (CN¥1.0B) exceed its short term liabilities (CN¥715.2M).
Long Term Liabilities: 002728's short term assets (CN¥1.0B) exceed its long term liabilities (CN¥34.5M).
Debt to Equity History and Analysis
Debt Level: 002728's net debt to equity ratio (2.3%) is considered satisfactory.
Reducing Debt: 002728's debt to equity ratio has reduced from 95.8% to 36.7% over the past 5 years.
Debt Coverage: 002728's debt is not well covered by operating cash flow (13.8%).
Interest Coverage: 002728 earns more interest than it pays, so coverage of interest payments is not a concern.